DMAC logo

DiaMedica Therapeutics (DMAC) Current Assets

Annual Current Assets

$53.67 M
+$19.84 M+58.64%

December 31, 2023

Summary

Performance

1-Year Change

+58.64%

3-Year Change

+92.24%

5-Year Change

+198.66%

15-Year Change

+3492.7%

DMAC Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.71%
DMAC annual total current assets is higher than 40.71% of companies in Healthcare sector

High & Low

All-time High

$53.67 M
DMAC annual total current assets is currently at an all-time high

3-Year Low

$33.84 M
DMAC annual total current assets is currently +58.64% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
DMAC previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 20, 2025
DMAC next annual earnings announcement is scheduled for Mar 20, 2025

OtherDMACbalance sheetmetrics:

Annual Total Assets

$54.16 M
DMAC annual total assets is $54.16 million

Annual Total Liabilities

$3.10 M
DMAC annual total liabilities is $3.10 million

Annual Current Liabilities

$2.79 M
DMAC annual total current liabilities is $2.79 million

Annual Total Long Term Liabilities

$317.00 K
DMAC annual total long term liabilities is $317.00 thousand

Quarterly Current Assets

$50.77 M
-$4.25 M-7.72%

September 30, 2024

Summary

Performance

3-Month Change

-7.72%

1-Year Change

+6.02%

3-Year Change

+4.59%

5-Year Change

+4.59%

DMAC Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.5%
DMAC quarterly total current assets is higher than 40.5% of companies in Healthcare sector

High & Low

All-time High

$55.01 M
DMAC quarterly total current assets is currently -7.72% below its historical high of $55.01 million

3-Year Low

$29.67 M
DMAC quarterly total current assets is currently +71.08% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
DMAC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 20, 2025
DMAC next earnings announcement is scheduled for Mar 20, 2025

OtherDMACbalance sheetmetrics:

Quarterly Total Assets

$52.52 M
DMAC quarterly total assets is $52.52 million

Quarterly Total Liabilities

$4.56 M
DMAC quarterly total liabilities is $4.56 million

Quarterly Current Liabilities

$4.30 M
DMAC quarterly total current liabilities is $4.30 million

Quarterly Long Term Liabilities

$263.00 K
DMAC quarterly total long term liabilities is $263.00 thousand

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

Annual Current Assets

$53.67 M
DMAC annual total current assets is $53.67 million

Annual Cash & Cash Equivalents

$4.54 M
DMAC annual cash & cash equivalents is $4.54 million

Annual Accounts Receivable

$71.00 K
DMAC annual accounts receivable is $71.00 thousand

Annual Inventory

-
DMAC annual inventory value is unknown

DMAC Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+58.6%+6.0%
3 y3 years+92.2%+4.6%
5 y5 years+198.7%+4.6%

DMAC Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+58.6%-7.7%+71.1%
5 y5-yearat high+507.5%-7.7%+474.6%
alltimeall timeat high>+9999.0%-7.7%>+9999.0%

DiaMedica Therapeutics Current Assets History

DateAnnualQuarterly
Sep 2024
-
$50.77 M(-7.7%)
Jun 2024
-
$55.01 M(+15.9%)
Mar 2024
-
$47.48 M(-11.5%)
Dec 2023
$485.00 K(-13.4%)
$53.67 M(+12.1%)
Sep 2023
-
$47.89 M(+16.1%)
Jun 2023
-
$41.23 M(+38.9%)
Mar 2023
-
$29.67 M(-12.3%)
Dec 2022
$560.00 K(+400.0%)
$33.84 M(-7.3%)
Sep 2022
-
$36.49 M(-6.8%)
Jun 2022
-
$39.17 M(-7.0%)
Mar 2022
-
$42.11 M(-7.3%)
Dec 2021
$112.00 K(-35.6%)
$45.44 M(-6.4%)
Sep 2021
-
$48.54 M(+124.4%)
Jun 2021
-
$21.63 M(-10.6%)
Mar 2021
-
$24.20 M(-13.3%)
Dec 2020
$174.00 K(-19.8%)
$27.92 M(-10.2%)
Sep 2020
-
$31.11 M(+150.9%)
Jun 2020
-
$12.40 M(-12.5%)
Mar 2020
-
$14.16 M(+60.3%)
Dec 2019
$217.00 K(-40.9%)
$8.84 M(-18.2%)
Sep 2019
-
$10.81 M(-12.0%)
Jun 2019
-
$12.28 M(-17.9%)
Mar 2019
-
$14.94 M(-16.8%)
Dec 2018
$367.00 K(+19.2%)
$17.97 M(+253.7%)
Sep 2018
-
$5.08 M(-16.1%)
Jun 2018
-
$6.06 M(-20.0%)
Mar 2018
-
$7.57 M(+406.6%)
Dec 2017
$308.00 K(+1521.1%)
$1.49 M(+49.4%)
Sep 2017
-
$999.80 K(-48.4%)
Jun 2017
-
$1.94 M(+84.3%)
Mar 2017
-
$1.05 M(-43.4%)
Dec 2016
$19.00 K(+32.9%)
$1.86 M(-40.1%)
Sep 2016
-
$3.10 M(+644.3%)
Jun 2016
-
$416.10 K(+11.9%)
Mar 2016
-
$371.80 K(+78.2%)
Dec 2015
$14.30 K
$208.70 K(+12.1%)
Sep 2015
-
$186.20 K(-63.9%)
DateAnnualQuarterly
Jun 2015
-
$516.30 K(+71.2%)
Mar 2015
-
$301.50 K(+13.3%)
Dec 2014
$15.60 K(-94.6%)
$266.20 K(-60.9%)
Sep 2014
-
$680.40 K(-51.6%)
Jun 2014
-
$1.41 M(-11.3%)
Mar 2014
-
$1.59 M(-39.4%)
Dec 2013
$288.90 K(-79.1%)
$2.62 M(+119.9%)
Sep 2013
-
$1.19 M(-46.8%)
Jun 2013
-
$2.24 M(-49.8%)
Mar 2013
-
$4.46 M(+81.2%)
Dec 2012
$1.38 M(-61.5%)
$2.46 M(-38.2%)
Sep 2012
-
$3.99 M(-1.4%)
Jun 2012
-
$4.04 M(+84.7%)
Mar 2012
-
$2.19 M(-20.0%)
Dec 2011
$3.59 M(-39.5%)
$2.74 M(-29.8%)
Sep 2011
-
$3.90 M(+111.0%)
Jun 2011
-
$1.85 M(-27.0%)
Mar 2011
-
$2.53 M(-19.5%)
Dec 2010
$5.94 M(+977.5%)
$3.14 M(+408.4%)
Sep 2010
-
$617.90 K(-74.1%)
Jun 2010
-
$2.38 M(+276.5%)
Mar 2010
-
$633.10 K(-8.9%)
Dec 2009
$550.90 K(+20.7%)
$694.60 K(-41.1%)
Sep 2009
-
$1.18 M(-21.8%)
Jun 2009
-
$1.51 M(-21.9%)
Mar 2009
-
$1.93 M(-24.1%)
Dec 2008
$456.60 K(-33.8%)
$2.54 M(-22.5%)
Sep 2008
-
$3.28 M(+16.6%)
Jun 2008
-
$2.81 M(-17.4%)
Mar 2008
-
$3.40 M(-6.7%)
Dec 2007
$690.00 K(+86.3%)
$3.65 M(-7.5%)
Sep 2007
-
$3.94 M(-9.6%)
Jun 2007
-
$4.37 M(-0.5%)
Mar 2007
-
$4.39 M(+1204.3%)
Dec 2006
$370.30 K(+51.6%)
$336.50 K(+44.0%)
Sep 2006
-
$233.70 K(-26.6%)
Dec 2005
$244.20 K(+29.4%)
$318.40 K
Dec 2004
$188.70 K
-

FAQ

  • What is DiaMedica Therapeutics annual total current assets?
  • What is the all time high annual current assets for DiaMedica Therapeutics?
  • What is DiaMedica Therapeutics annual current assets year-on-year change?
  • What is DiaMedica Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for DiaMedica Therapeutics?
  • What is DiaMedica Therapeutics quarterly current assets year-on-year change?

What is DiaMedica Therapeutics annual total current assets?

The current annual current assets of DMAC is $53.67 M

What is the all time high annual current assets for DiaMedica Therapeutics?

DiaMedica Therapeutics all-time high annual total current assets is $53.67 M

What is DiaMedica Therapeutics annual current assets year-on-year change?

Over the past year, DMAC annual total current assets has changed by +$19.84 M (+58.64%)

What is DiaMedica Therapeutics quarterly total current assets?

The current quarterly current assets of DMAC is $50.77 M

What is the all time high quarterly current assets for DiaMedica Therapeutics?

DiaMedica Therapeutics all-time high quarterly total current assets is $55.01 M

What is DiaMedica Therapeutics quarterly current assets year-on-year change?

Over the past year, DMAC quarterly total current assets has changed by +$2.88 M (+6.02%)